Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T20:40:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The NCT02872259 study page now displays a 403 Forbidden error instead of the study record content, with the standard header/footer shown; the content previously containing the trial details has been removed.
    Difference
    19%
    Check dated 2026-09-20T22:23:16.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page adds links and references to Melanoma-related topics and MedlinePlus Genetics resources, providing readers with external health information related to the study topic.
    Difference
    0.2%
    Check dated 2026-09-13T17:57:45.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The related topics section loses entries for Melanoma and MedlinePlus Genetics. The related topics header is removed, reducing navigation to melanoma-related topics and genetics resources.
    Difference
    0.2%
    Check dated 2026-09-06T22:28:32.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the page's related topics, and the revision tag was updated from v3.6.5 to v3.6.6, indicating a small metadata update.
    Difference
    0.2%
    Check dated 2026-08-30T22:38:50.000Z thumbnail image
  8. Check
    54 days ago
    Change Detected
    Summary
    Removed the 'Melanoma' condition label from the study overview and deleted the 'related topics' header along with the MedlinePlus Genetics link in the related topics section.
    Difference
    0.2%
    Check dated 2026-08-23T19:54:01.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.